• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GENENTA SCIENCE SPA

Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
October 23, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
October 02, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers ARYD GNTA SQZ
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
February 08, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Genenta to Present at Upcoming Scientific and Investor Conferences
September 06, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
July 28, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
June 29, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Genenta to Provide Update on Lead Product Temferon™
May 16, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
April 26, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap